Business News • PR NewsWire • Profil Institute and Rosa Announce Strategic Partnership Offering Newest Simulation Technology to Enhance Diabetes and Obesity Clinical Trials

Profil Institute and Rosa Announce Strategic Partnership Offering Newest Simulation Technology to Enhance Diabetes and Obesity Clinical Trials

Profil Institute and Rosa Announce Strategic Partnership Offering Newest Simulation Technology to Enhance Diabetes and Obesity Clinical Trials

SAN DIEGO and SAN CARLOS, Calif., June 8, 2011 /PRNewswire/ -- Profil™ Institute for Clinical Research, Inc., a company leading the industry in early phase clinical trials for diabetes and obesity, and Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling

View More : http://www.prnewswire.com/news-releases/profil-institute-and-rosa-announce-strategic-partnership-offering-newest-simulat...

Releted News by prnewswire

Reportlinker Adds Markets for OLED Materials

NetMotion Wireless Announces Participation in Emergency Management All Hazards-All Stakeholders Summit Series

New Study From Saatchi & Saatchi S Shows Majority of Americans Want Gamification at Work and From Brands